News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Cientifica de VIVA in Vitro trabajando en sus laboratorios
Sepsis causes up to 20,000 annual deaths in Spain: Biotechnology is revolutionizing early diagnosis
Healthcare · Personalized medicine
Viva In Vitro, an AseBio member, has developed VIVA-ELISA, a biotechnology tool that rapidly…
Médico
Life Sciences Strategy: Europe’s commitment to remain a global leader in health
Healthcare
Growing investment in R&D, eliminating unnecessary bureaucratic hurdles, and creating…
Imágende SafeHeal®
Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financing to Accelerate Commercialization of Colovac®
Healthcare · Access to innovation · Financing
Asabys joins SafeHeal’s global investor syndicate, which includes Sofinnova, Solar Eclipse and a…
Rodríguez González, consejero de Educación, Ciencia, Universidades y Formación Profesional de la Xunta de Galicia
#BIOSPAIN2025 | “Hosting international events and participating as sponsors in key gatherings such as BIOSPAIN help strengthen Galicia’s visibility and positioning as a leading player in biotechnology, health, and advanced research"
BioSpain
We interviewed Román Rodríguez González, Regional Minister of Education, Science, Universities and…
Agricultor en un campo de cultivo
Biotechnology and Regenerative Agriculture: The alliance for the future of farming
Climate change · Agrifood · Food & feed · Agriculture
Regenerative Agriculture aims to restore agricultural ecosystems through healthier soils, resilient…
BIOSPAIN 2023 celebrado en la Fira de Barcelona
BIOSPAIN becomes an annual event, consolidating its leadership as a driving force of the Spanish biotechnology sector
BioSpain
The host city for BIOSPAIN 2026 will be announced during the official events at BIOSPAIN 2025,…
Científicos analizando muestras en un laboratorio
CONNECTA Therapeutics to Advance CTH120 into Phase II Pediatric Development for Fragile X Syndrome with EIC Accelerator Support
Healthcare · Access to innovation · Financing
CTH120 is a first-in-class neuroplasticity modulator with strong Phase I safety and tolerability…
Avencia Sánchez Mejías, CEO de Integra Therapeutics
Integra Therapeutics secures €10.7 million investment round to advance development of FiCAT gene writing platform and preclinical validation of CAR-T therapies
Healthcare · Advanced therapies · Financing
The investment combines funds from new investors like the EIC Fund (European Commission) and CDTI…
 Talking Science in Summer: Bionet is making bioprocessing easier to understand
Talking Science in Summer: Bionet is making bioprocessing easier to understand
Access to innovation
Bioprocessing is full of complex terms and concepts that can be difficult to digest. This summer,…